Geulah Livshits
Stock Analyst at Chardan Capital
(4.32)
# 1,294
Out of 4,456 analysts
653
Total ratings
38.5%
Success rate
9.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PVLA Palvella Therapeutics | Reiterated: Buy | $240 | $148.21 | +61.93% | 12 | May 20, 2026 | |
| IMTX Immatics | Reiterated: Buy | $25 | $9.53 | +162.33% | 22 | May 19, 2026 | |
| IMRX Immuneering | Reiterated: Buy | $20 | $4.76 | +320.17% | 15 | May 19, 2026 | |
| SNTI Senti Biosciences Holdings | Reiterated: Buy | $13 → $12 | $1.09 | +1,000.92% | 12 | May 15, 2026 | |
| TNYA Tenaya Therapeutics | Reiterated: Buy | $8 | $0.7175 | +1,014.98% | 21 | May 15, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $15 | $9.29 | +61.46% | 12 | May 13, 2026 | |
| MGX Metagenomi Therapeutics | Reiterated: Buy | $7 | $1.25 | +462.25% | 7 | May 13, 2026 | |
| LXEO Lexeo Therapeutics | Reiterated: Buy | $17 | $4.75 | +257.89% | 13 | May 11, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $11 | $3.25 | +238.46% | 39 | May 10, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $26 | $11.60 | +124.14% | 17 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.43 | +162.39% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $14 | $4.25 | +229.41% | 53 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $6.34 | +89.27% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 → $4 | $2.85 | +40.35% | 43 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $13.08 | +68.20% | 1 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $54.92 | +38.38% | 57 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 | $372.25 | -13.23% | 24 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $30 | $16.68 | +79.86% | 51 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $21 | $4.70 | +346.81% | 17 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $67.27 | - | 41 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €1.00 | $0.2345 | +326.44% | 8 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $7 | $2.32 | n/a | 7 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.58 | n/a | 23 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 → $36 | $12.11 | n/a | 18 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $47.51 | n/a | 6 | Aug 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.04 | n/a | 11 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8885 | n/a | 12 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.29 | n/a | 3 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $9.07 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €15.00 | $0.0803 | n/a | 7 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $76 | $10.48 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $6 | $3.59 | n/a | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $15 | $13.17 | n/a | 10 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $20 | $38.85 | n/a | 3 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.0127 | n/a | 5 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $21 | $19.96 | n/a | 2 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 17 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $48 | $11.63 | n/a | 9 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $2.00 | n/a | 1 | Jun 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $21.03 | n/a | 10 | Feb 20, 2020 |
Palvella Therapeutics
May 20, 2026
Reiterated: Buy
Price Target: $240
Current: $148.21
Upside: +61.93%
Immatics
May 19, 2026
Reiterated: Buy
Price Target: $25
Current: $9.53
Upside: +162.33%
Immuneering
May 19, 2026
Reiterated: Buy
Price Target: $20
Current: $4.76
Upside: +320.17%
Senti Biosciences Holdings
May 15, 2026
Reiterated: Buy
Price Target: $13 → $12
Current: $1.09
Upside: +1,000.92%
Tenaya Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $0.7175
Upside: +1,014.98%
Solid Biosciences
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $9.29
Upside: +61.46%
Metagenomi Therapeutics
May 13, 2026
Reiterated: Buy
Price Target: $7
Current: $1.25
Upside: +462.25%
Lexeo Therapeutics
May 11, 2026
Reiterated: Buy
Price Target: $17
Current: $4.75
Upside: +257.89%
Rocket Pharmaceuticals
May 10, 2026
Reiterated: Buy
Price Target: $11
Current: $3.25
Upside: +238.46%
4D Molecular Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $26
Current: $11.60
Upside: +124.14%
May 8, 2026
Reiterated: Buy
Price Target: $9
Current: $3.43
Upside: +162.39%
May 7, 2026
Reiterated: Buy
Price Target: $16 → $14
Current: $4.25
Upside: +229.41%
May 6, 2026
Reiterated: Buy
Price Target: $12
Current: $6.34
Upside: +89.27%
May 5, 2026
Reiterated: Buy
Price Target: $3.5 → $4
Current: $2.85
Upside: +40.35%
May 5, 2026
Maintained: Buy
Price Target: $22
Current: $13.08
Upside: +68.20%
May 4, 2026
Reiterated: Buy
Price Target: $76
Current: $54.92
Upside: +38.38%
May 4, 2026
Reiterated: Buy
Price Target: $323
Current: $372.25
Upside: -13.23%
Apr 27, 2026
Maintained: Buy
Price Target: $27 → $30
Current: $16.68
Upside: +79.86%
Nov 12, 2025
Maintained: Buy
Price Target: $120 → $21
Current: $4.70
Upside: +346.81%
Oct 7, 2025
Rated: Hold
Price Target: n/a
Current: $67.27
Upside: -
Sep 17, 2025
Maintained: Buy
Price Target: €1.00
Current: $0.2345
Upside: +326.44%
Mar 24, 2025
Maintained: Buy
Price Target: $11 → $7
Current: $2.32
Upside: n/a
Jan 29, 2024
Reiterated: Buy
Price Target: n/a
Current: $4.58
Upside: n/a
Dec 21, 2023
Reiterated: Buy
Price Target: $41 → $36
Current: $12.11
Upside: n/a
Aug 25, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $47.51
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $12
Current: $3.04
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.8885
Upside: n/a
Jan 6, 2023
Rated: Hold
Price Target: n/a
Current: $6.29
Upside: n/a
Dec 14, 2022
Maintained: Buy
Price Target: $11
Current: $9.07
Upside: n/a
Jul 28, 2022
Reiterated: Buy
Price Target: €15.00
Current: $0.0803
Upside: n/a
Mar 29, 2022
Maintained: Buy
Price Target: $90 → $76
Current: $10.48
Upside: n/a
Mar 9, 2022
Reiterated: Hold
Price Target: $4 → $6
Current: $3.59
Upside: n/a
Feb 22, 2022
Reiterated: Buy
Price Target: $25 → $15
Current: $13.17
Upside: n/a
Jan 5, 2022
Reiterated: Buy
Price Target: $22 → $20
Current: $38.85
Upside: n/a
Dec 17, 2021
Reiterated: Buy
Price Target: $30
Current: $0.0127
Upside: n/a
Aug 20, 2021
Reiterated: Buy
Price Target: $18 → $21
Current: $19.96
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Oct 14, 2020
Maintained: Buy
Price Target: $30 → $48
Current: $11.63
Upside: n/a
Jun 4, 2020
Initiated Coverage: Buy
Price Target: $28
Current: $2.00
Upside: n/a
Feb 20, 2020
Reiterated: Hold
Price Target: $1
Current: $21.03
Upside: n/a